phorbolol myristate acetate has been researched along with withaferin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, JS; Han, MS; Ku, SK | 1 |
1 other study(ies) available for phorbolol myristate acetate and withaferin a
Article | Year |
---|---|
Withaferin A is an inhibitor of endothelial protein C receptor shedding in vitro and in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Anti-Inflammatory Agents; Blood Coagulation Factors; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Cell Surface; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Withanolides | 2014 |